Related Experiment Video
Updated: Jul 8, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein
J R Wispé1, J C Clark, B B Warner
1University of Cincinnati, Department of Pediatrics, Ohio 45267-0541.
Abstract:
Tumor necrosis factor-alpha (TNF-alpha) decreased the expression of pulmonary surfactant proteins SP-A and SP-B in human pulmonary adenocarcinoma cell lines. The effect of TNF alpha on SP-A content and mRNA in the pulmonary adenocarcinoma cell line, H441-4, was concentration and time dependent. TNF alpha decreased the cellular content of SP-A to less than 10% of control 48 h after addition. TNF alpha decreased de novo synthesis of SP-A and decreased the accumulation of SP-A in media. SP-A mRNA was decreased within 12 h of addition of TNF alpha, with nearly complete loss of SP-A mRNA observed after 24 h. Inhibitory effects of TNF alpha on SP-A mRNA were dose-related with nearly complete inhibition of SP-A mRNA caused by 25 ng/ml TNF alpha. The effects of TNF alpha on SP-A were distinct from the effects of interferon gamma which increased SP-A content approximately twofold in H441-4 cells. TNF alpha also decreased the content of SP-B mRNA. In contrast to the inhibitory effect of TNF alpha on SP-A and SP-B mRNA, TNF alpha increased mRNA encoding human manganese superoxide dismutase (Mn-SOD). TNF alpha did not inhibit growth, alter cell viability or beta-actin mRNA in either cell line. These in vitro studies demonstrate the marked pretranslational inhibitory effects of the cytokine, TNF alpha, on the expression of pulmonary surfactant proteins, SP-A and SP-B. The results support the concept that macrophage-derived cytokines may control surfactant protein expression.
Insights
Tumor necrosis factor-alpha (TNF-alpha) inhibits pulmonary surfactant protein A (SP-A) and SP-B expression in lung cancer cells. This cytokine significantly reduces SP-A mRNA levels in a dose- and time-dependent manner.
Area of Science:
- Pulmonary Medicine
- Cell Biology
- Immunology
Background:
- Pulmonary surfactant proteins (SP-A and SP-B) are crucial for lung function.
- Tumor necrosis factor-alpha (TNF-alpha) is a pro-inflammatory cytokine implicated in various diseases.
Purpose of the Study:
- To investigate the effect of TNF-alpha on the expression of SP-A and SP-B in human pulmonary adenocarcinoma cell lines.
- To elucidate the molecular mechanisms underlying TNF-alpha's influence on surfactant protein synthesis.
Main Methods:
- Exposure of pulmonary adenocarcinoma cell lines (H441-4) to varying concentrations and durations of TNF-alpha.
- Quantification of SP-A and SP-B mRNA and protein levels using molecular biology techniques.
- Assessment of cell viability and beta-actin mRNA to control for non-specific effects.
Main Results:
- TNF-alpha significantly decreased SP-A content and mRNA levels in a dose- and time-dependent manner, reducing SP-A to <10% of control within 48 hours.
- SP-A mRNA levels decreased within 12 hours, with near-complete loss after 24 hours, indicating pretranslational inhibition.
- TNF-alpha also decreased SP-B mRNA levels but increased manganese superoxide dismutase (Mn-SOD) mRNA, while not affecting cell viability or growth.
Conclusions:
- TNF-alpha exerts a marked pretranslational inhibitory effect on the expression of pulmonary surfactant proteins SP-A and SP-B in lung adenocarcinoma cells.
- These findings suggest that macrophage-derived cytokines like TNF-alpha may play a role in regulating surfactant protein expression in the lung.
Related Concept Videos
Breathing
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Regulation of Angiogenesis and Blood Supply
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

